> Healthy News > Ivabradine Launch

Ivabradine Launch

Posted on March 13, 2018 | No Comments on Ivabradine Launch

When the body is under stress especially during intense physical activities, the body tend to supply insufficient blood and oxygen to the heart.  This scarcity of oxygen causes chest pains which is called angina.  Recently launched at the EDSA shangri-la Ballroom, Coralan (Ivabradine) is a heart-rate lowering medication intended for chest pain management (chronic stable angina).  Ivabradine acts as a heart-rate lowering agent that can settle the body for proper circulation.

Ivabradine targets the main goal of angina which is to lower heart-rate of patients with coronary artery disease.  It is a prescription drug which is non-addictive and does not have the side effects associated with other types of medications present in the market.

However, Ivabradine is not intended for sudden attacks of chest pains.  It is always best to consult a doctor for any cardiac concerns.

Related terms:

Related Posts:

» Tags: , ,

Related terms:

Leave a Reply

Your email address will not be published. Required fields are marked *